drugset / Trial / NCT00895011

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

NCT00895011

Phase 3 Completed 298 enrolled VIVUS LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

Timeline

Start
2009-04
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Avanafil Small molecule 100 mg
Subject Avanafil Small molecule 200 mg

Indications